First immunotherapy for advanced endometrial cancer approved in the UK Open Access Government
NICE recommends Keytruda for endometrial cancer The Pharma Letter
Globally, endometriosis affects almost 10% of reproductive-aged women, leading to chronic pain and discomfort. Endocrine-disrupting compounds (EDCs) seem to play a pivotal role as a causal factor. The current manuscript …
Endometriosis (EMS) is a prevalent estrogen-dependent gynecological disorder characterized by ectopic growth of endometrial tissue. Central to its pathophysiology, peritoneal CD14hi macrophages exhibit a pro-EMS phenotype and drive disease progression. …
Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by the ectopic presence of endometrial-like tissue. Although genome-wide association studies (GWAS) have identified susceptibility variants, their tissue-specific regulatory impact remains poorly …
Extra-pelvic endometriosis, defined as the presence of endometrial tissue or stroma outside of the pelvic cavity, is a rare cause of hemothorax and hemoperitoneum. Here, we present a case of …
NICE approves first immunotherapy combination for endometrial cancer NICE website
Potential Causal Link Between Gut Microbiota and Endometrial Cancer Docwire News
Potential Causal Link Between Gut Microbiota and Endometrial Cancer docwirenews.com
LPMs absence enhances inflammation and accumulation of dead endometrial... researchgate.net